Multiple mechanisms, including 5′-adenosine monophosphate-activated protein kinase AMPK-dependent and AMPK-independent mechanisms, have been suggested for the metformin effect in cancer treatment [5, 6]. The gene discussed is PRKAA1; the disease is cancer.